Clinical and metabolic effects of the monophasic gestodene/ethinylestradiol pill for contraception during adolescence
- 31 May 1991
- journal article
- Published by Elsevier in Adolescent and Pediatric Gynecology
- Vol. 4 (2) , 76-81
- https://doi.org/10.1016/s0932-8610(12)80204-0
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Prostaglandins: PGF2α, PGE2, 6-keto-PGF1α and TXB2 serum levels in dysmenorrheic adolescents before, during and after treatment with oral contraceptivesEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 1990
- Clinical aspects of three new progestogens: Desogestrel, gestodene, and norgestimateAmerican Journal of Obstetrics and Gynecology, 1989
- Effects of Two Triphasic Oral Contraceptives Containing Ethinylestradiol Plus Levonorgestrel or Gestodene on Blood Coagulation and FibrinolysisActa Obstetricia et Gynecologica Scandinavica, 1989
- Adolescent contraception: An overviewAdolescent and Pediatric Gynecology, 1988
- New progestogens in oral contraceptivesAmerican Journal of Obstetrics and Gynecology, 1987
- The short-term effects of a low-dose oral contraceptive on glucose metabolism, plasma lipids and blood clotting factorsContraception, 1983